BioAdaptives, Inc.
BDPT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $3 | $0 | $0 |
| % Growth | 43.9% | – | – | – |
| Cost of Goods Sold | $1 | $2 | $0 | $20 |
| Gross Profit | $4 | $1 | $0 | $20 |
| % Margin | 83.1% | 33% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $268 | $279 | $249 | $337 |
| SG&A Expenses | $268 | $279 | $249 | $337 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Expenses | $269 | $280 | $249 | $337 |
| Operating Income | -$266 | -$279 | -$249 | -$337 |
| % Margin | -5,735.9% | -8,674.1% | – | – |
| Other Income/Exp. Net | -$114 | $121 | $52 | -$34 |
| Pre-Tax Income | -$380 | -$158 | -$197 | -$372 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$380 | -$158 | -$197 | -$372 |
| % Margin | -8,193% | -4,905.7% | – | – |
| EPS | -0.04 | -0.017 | -0.022 | -0.038 |
| % Growth | -141% | 23.9% | 41.9% | – |
| EPS Diluted | -0.04 | -0.017 | -0.022 | -0.038 |
| Weighted Avg Shares Out | 10,239 | 9,533 | 9,049 | 9,911 |
| Weighted Avg Shares Out Dil | 10,239 | 9,533 | 9,049 | 9,911 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $10 | $10 | $10 |
| Depreciation & Amortization | $77 | $1 | $0 | $0 |
| EBITDA | -$289 | -$147 | -$249 | -$362 |
| % Margin | -6,235.9% | -4,574.9% | – | – |